Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 11:48 PM
Study NCT ID:
NCT01121094
Status:
UNKNOWN
Last Update Posted:
2010-05-12
First Post:
2010-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* Sequences
Sponsor:
Sheba Medical Center
Organization:
Study Overview
Official Title:
Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* Sequences.
Status:
UNKNOWN
Status Verified Date:
2010-05
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to prospectively evaluated the T2\* values of normal feti.A standardized scale of T2\* values for fetal and neonatal iron organ overload have yet to be reported or devised.
Detailed Description:
The purpose of this study is to prospectively evaluate the T2\* values of normal feti. This study will be offered to mothers undergoing fetal MRI for any indication. Subjects will be required to sign an informed consent from. The addition of T2\* sequences will add 2-4 minutes to the whole scan, not exposing the mother or the fetus to ionizing radiation or the administration of contrast material. A standardized scale has been created and multi-center studies have been conducted using different vendor scanners in order to verify the consistency of these scale. T2 and T2\* sequences have been addressed anecdotally in the literature as non invasive options for the evaluation fetal iron deposition . However, a standardized scale of T2\* values for fetal and neonatal iron organ overload have yet to be reported or devised.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: